Atlas Trials

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Clinical trial NCT07319793 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07319793
Sponsor
Peking University People's Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Start date
2026-01-01
Primary completion
2027-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.